(Q33809754)

29 July 2017

1 reference

title

Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? (English)

1 reference

29 July 2017

0 references

Lader MH

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

European Neuropsychopharmacology

29 July 2017

published in

1 reference

29 July 2017

volume

9 Suppl 6

1 reference

29 July 2017

page(s)

S399-405

1 reference

Guidelines for the rational use of benzodiazepines. When and what to use.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Lorazepam in the elderly--a retrospective study of the side-effects in 20 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Physiological and psychological measures in anxious patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Abuse of flunitrazepam (Rohypnol) and other benzodiazepines in Austin and south Texas

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Benzodiazepines, memory and mood: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Long-Term Outcome of Panic States During Double-Blind Treatment and After Withdrawal of Alprazolam and Placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Psychological treatment of generalised anxiety disorder. A review of the clinical significance of results in outcome studies since 1980.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Untreated anxiety among adult primary care patients in a Health Maintenance Organization

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Benzodiazepines and vigilance performance: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Rebound insomnia and newer hypnotics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

The role of drugs in falls in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Pharmacological treatment of insomnia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Risk of traffic accident injury after a prescription for a benzodiazepine☆

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Hypnotics. Their place in therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Treatment outlines for the management of anxiety states. The Quality Assurance Project

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Long-term Treatment of Anxiety and Risk of Withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

The Drug Treatment of Anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Why low-dose benzodiazepine-dependent insomniacs can't escape their sleeping pills

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Fatal poisonings attributed to benzodiazepines in Britain during the 1980s

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Snorting benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

Intravenous and other novel abuses of benzodiazepines: the opening of Pandora's box?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

The Nottingham study of neurotic disorder: comparison of drug and psychological treatments.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900051-6

7 January 2021

10.1016/S0924-977X(99)00051-6

Identifiers

DOI

1 reference

29 July 2017

1 reference